Recruiting OBSERVATIONAL NCT07108920

Analysis of Balance Disorders After Botulinum Toxin Treatment in the Rectus Femoris in Patients With a Stiff Knee Gait (FEMFALLTOX)

Analysis of Balance Disorders After Botulinum Toxin Treatment in the Rectus Femoris in Patients With a Stiff Knee Gait: What About the Risk of Falls?

Sponsor: Hopital Nord Franche-Comte

Conditions Botox Injection Botulinum Toxin Injection Fall Risk Rectus Femoris Muscle Spasticity With Multiple Sclerosis Stiff Knee Gait

Interventions Functional clinical tests

Updated 2 times since 2025 Last updated: Sep 19, 2025 Started: Oct 1, 2025 Primary completion: Aug 1, 2026 Completion: Aug 1, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Botox Injection and Botulinum Toxin Injection and is currently actively recruiting participants. Hopital Nord Franche-Comte leads this study, which shows 2 recorded versions since 2025 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

2 versions recorded

Oct 2025 — Present [monthly]

Recruiting
Sep 2025 — Oct 2025 [monthly]

Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hopital Nord Franche-Comte

Data source: Hopital Nord Franche-Comte

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Héricourt, France